Ana
Fernández Montes
Francis Crick Institute
Londres, Reino UnidoPublicacións en colaboración con investigadores/as de Francis Crick Institute (1)
2021
-
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
The Lancet Oncology, Vol. 22, Núm. 6, pp. 765-778